HIGHLIGHTS
- who: Mohsen Nabi-Meybodi from the The study protocol was approved by the Ethics Committee of Shahid Sadoughi University of Medical Sciences (IRSSU.MEDICINE.REC.1399.058) and registered in the Iranian Registry of Clinical Trials (IRCT, ). Informed consent was obtained from all subjects or their legal guardians. All experiments were performed in accordance with relevant guidelines and regulations. have published the article: Effects of topical timolol for the prevention of radiation-induced dermatitis in breast cancer: a pilot triple-blind, placebo-controlled trial, in the Journal: (JOURNAL)
- what: The current trial aimed to evaluate . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.